While the condition is the major cause of poor vitamin B 12 status in the elderly population, it is usually associated with atrophic gastritis, a chronic inflammation of the lining of the stomach that ultimately results in the loss of glands in the stomach (atrophy) and decreased stomach acid production (see Atrophic gastritis)
Retatrutide and cagrilintide are both investigational drugs not approved by the FDA
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Tesamorelin Peptide: Benefits, Uses, Side Effects, Dosage, and Research
Key: CblC
Topical anti-inflammatory medicines can be used
We always recommend you speak to your doctor before embarking on this treatment plan